Release of interleukin-1 α or interleukin-1 β depends on mechanism of cell death

Journal of Biological Chemistry

Volumn 289, Issue 23, 2014, Pages 15942-15950

  England, Hazel ^a   Summersgill, Holly R ^a   Edye, Michelle E ^a   Rothwell, Nancy J ^a   Brough, David ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PATHOLOGY;

APOPTOTIC; CALPAINS; CASPASES; CELL-DEATH PATHWAYS; CYTOKINES; HOST RESPONSE; INTERLEUKIN-1; PRECURSOR PROTEINS;

CELL DEATH;

CALPAIN; CASPASE 8; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA;

ADULT; ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DEATH; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE RELEASE; MALE; MOUSE; NECROPTOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING; PROTEIN SECRETION; SIGNAL TRANSDUCTION;

APOPTOSIS; CALPAIN; CASPASE; CELL DEATH; INFLAMMATION; INTERLEUKIN; MACROPHAGE; NECROSIS (NECROTIC DEATH);

ANIMALS; APOPTOSIS; CALCIUM; CALPAIN; CASPASE 8; CELLS, CULTURED; INTERLEUKIN-1ALPHA; INTERLEUKIN-1BETA; MICE; MICE, INBRED C57BL; NECROSIS;

EID: 84902142180     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M114.557561     Document Type: Article

References (39)

1. Rock, K. L., Latz, E., Ontiveros, F., and Kono, H. (2010) The sterile inflammatory response. Annu. Rev. Immunol. 28, 321-342
2. Dinarello, C. A., Simon, A., and van der Meer, J. W. (2012) Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases. Nat. Rev. Drug Discov. 11, 633-652
3. Reardon, S. (2011) A world of chronic disease. Science 333, 558-559
4. Angell, S. Y., Danel, I., and DeCock, K. M. (2012) Global health: global indicators and targets for noncommunicable diseases. Science 337, 1456-1457
5. O'Neill, L. A. (2008) The interleukin-1 receptor/Toll-like receptor superfamily: 10 years of progress. Immunol. Rev. 226, 10-18
6. Dinarello, C. A. (2013) Overview of the interleukin-1 family of ligands and receptors. Semin. Immunol. 25, 389-393
7. Schroder, K., and Tschopp, J. (2010) The inflammasomes. Cell 140, 821-832
8. Gross, O., Yazdi, A. S., Thomas, C. J., Masin, M., Heinz, L. X., Guarda, G., Quadroni, M., Drexler, S. K., and Tschopp, J. (2012) Inflammasome activators induce interleukin-1a secretion via distinct pathways with differential requirement for the protease function of caspase-1. Immunity 36, 388-400
9. Luheshi, N. M., Rothwell, N. J., and Brough, D. (2009) Dual functionality of interleukin-1 family cytokines: implications for anti-interleukin-1 therapy. Br. J. Pharmacol. 157, 1318-1329
10. Kim, B., Lee, Y., Kim, E., Kwak, A., Ryoo, S., Bae, S. H., Azam, T., Kim, S., and Dinarello, C. A. (2013) The interleukin-1a precursor is biologically active and is likely a key alarmin in the IL-1 family of cytokines. Front. Immunol. 4, 391
11. Afonina, I. S., Tynan, G. A., Logue, S. E., Cullen, S. P., Bots, M., Lüthi, A. U., Reeves, E. P., McElvaney, N. G., Medema, J. P., Lavelle, E. C., and Martin, S. J. (2011) Granzyme B-dependent proteolysis acts as a switch to enhance the proinflammatory activity of IL-1 α. Mol. Cell 44, 265-278
12. Zheng, Y., Humphry, M., Maguire, J. J., Bennett, M. R., and Clarke, M. C. (2013) Intracellular interleukin-1 receptor 2 binding prevents cleavage and activity of interleukin-1a, controlling necrosis-induced sterile inflammation. Immunity 38, 285-295
13. Clarke, M. C, Talib, S., Figg, N. L., and Bennett, M. R. (2010) Vascular smooth muscle cell apoptosis induces interleukin-1-directed inflammation: effects of hyperlipidemia-mediated inhibition of phagocytosis. Circ. Res. 106, 363-372
14. Eigenbrod, T., Park, J. H, Harder, J., Iwakura, Y., and Núñez, G. (2008) Cutting edge: critical role for mesothelial cells in necrosis-induced inflammation through the recognition of IL-1a released from dying cells. J. Immunol. 181, 8194-8198
15. Shimada, K., Crother, T. R., Karlin, J., Dagvadorj, J., Chiba, N., Chen, S., Ramanujan, V. K., Wolf, A. J., Vergnes, L., Ojcius, D. M., Rentsendorj, A., Vargas, M., Guerrero, C, Wang, Y., Fitzgerald, K. A., Underhill, D. M., Town, T., and Arditi, M. (2012) Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis. Immunity 36, 401-414
16. Bossaller, L., Chiang, P. I., Schmidt-Lauber, C, Ganesan, S., Kaiser, W. J., Rathinam, V. A., Mocarski, E. S., Subramanian, D., Green, D. R., Silverman, N., Fitzgerald, K. A., Marshak-Rothstein, A., and Latz, E. (2012) Cutting edge: FAS (CD95) mediates noncanonical IL-1β and IL-18 maturation via caspase-8 in an RIP3-independent manner. J. Immunol. 189, 5508-5512
17. Antonopoulos, C, El Sanadi, C, Kaiser, W. J., Mocarski, E. S., and Dubyak, G. R. (2013) Proapoptotic chemotherapeutic drugs induce noncanonical processing and release of IL-1 β via caspase-8 in dendritic cells. J. Immunol. 191, 4789-4803
18. Mariathasan, S., Newton, K., Monack, D. M., Vucic, D., French, D. M., Lee, W. P., Roose-Girma, M., Erickson, S., and Dixit, V. M. (2004) Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf. Nature 430, 213-218
19. Mariathasan, S., Weiss, D. S., Newton, K., McBride, J., O'Rourke, K., Roose-Girma, M., Lee, W. P., Weinrauch, Y., Monack, D. M., and Dixit, V. M. (2006) Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 440, 228-232
20. Lopez-Castejon, G., Theaker, J., Pelegrin, P., Clifton, A. D., Braddock, M., and Surprenant, A. (2010) P2X (7) receptor-mediated release of cathepsins from macrophages is a cytokine-independent mechanism potentially involved in joint diseases. J. Immunol. 185, 2611-2619
21. Le Feuvre, R. A., Brough, D., Iwakura, Y., Takeda, K., and Rothwell, N. J. (2002) Priming of macrophages with lipopolysaccharide potentiates P2X7-mediated cell death via a caspase-1-dependent mechanism, independently of cytokine production. J. Biol. Chem. 277, 3210-3218
22. Zhang, D. W., Shao, J., Lin, J., Zhang, N, Lu, B. J., Lin, S. C, Dong, M. Q., and Han, J. (2009) RIP3, an energy metabolism regulator that switches TNF-induced cell death from apoptosis to necrosis. Science 325, 332-336
23. Degterev, A., Huang, Z., Boyce, M., Li, Y., Jagtap, P., Mizushima, N, Cuny, G. D., Mitchison, T. J., Moskowitz, M. A., and Yuan, J. (2005) Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury. Nat Chem. Biol. 1, 112-119
24. Degterev, A., Hitomi, J., Germscheid, M., Ch'en, I. L., Korkina, O., Teng, X., Abbott, D., Cuny, G. D., Yuan, C, Wagner, G., Hedrick, S. M., Gerber, S. A., Lugovskoy, A., and Yuan, J. (2008) Identification of RIP1 kinase as a specific cellular target of necrostatins. Nat. Chem. Biol. 4, 313-321
25. Carruth, L. M., Demczuk, S., and Mizel, S. B. (1991) Involvement of a calpain-like protease in the processing of the murine interleukin 1a precursor. J. Biol. Chem. 266, 12162-12167
26. Man, S. M., Tourlomousis, P., Hopkins, L., Monie, T. P., Fitzgerald, K. A., and Bryant, C. E. (2013) Salmonella infection induces recruitment of caspase-8 to the inflammasome to modulate IL-1β production. J. Immunol. 191, 5239-5246
27. Gurung, P., Anand, P. K., Malireddi, R. K., Vande Walle, L., Van Opdenbosch, N, Dillon, C. P., Weinlich, R., Green, D. R., Lamkanfi, M., and Kanneganti, T. D. (2014) FADD and caspase-8 mediate priming and activation of the canonical and noncanonical Nlrp3 inflammasomes. J. Immunol. 192, 1835-1846
28. Vandenabeele, P., Galluzzi, L., Vanden Berghe, T., and Kroemer, G. (2010) Molecular mechanisms of necroptosis: an ordered cellular explosion. Nat. Rev. Mol. Cell Biol. 11, 700-714
29. Han, J., Zhong, C. Q., and Zhang, D. W. (2011) Programmed necrosis: backup to and competitor with apoptosis in the immune system. Nat. Immunol. 12, 1143-1149
30. Cho, Y. S., Challa, S., Moquin, D., Genga, R., Ray, T. D., Guildford, M., and Chan, F. K. (2009) Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation. Cell 137, 1112-1123
31. He, S., Wang, L., Miao, L., Wang, T., Du, F., Zhao, L., and Wang, X. (2009) Receptor interacting protein kinase-3 determines cellular necrotic responsetoTNF-α. Cell 137, 1100-1111
32. Smith, C. C, Davidson, S. M., Lim, S. Y., Simpkin, J. C, Hothersall, J. S., and Yellon, D. M. (2007) Necrostatin: a potentially novel cardioprotective agent? Cardiovasc. Drugs Ther. 21, 227-233
33. Northington, F. J., Chavez-Valdez, R., Graham, E. M., Razdan, S., Gauda, E. B., and Martin, L. J. (2011) Necrostatin decreases oxidative damage, inflammation, and injury after neonatal HI. J. Cereb. Blood Flow Metab. 31, 178-189
34. Toldo, S., Schatz, A. M., Mezzaroma, E., Chawla, R., Stallard, T. W., Stallard, W. C, Jahangiri, A., Van Tassell, B. W., and Abbate, A. (2012) Recombinant human interleukin-1 receptor antagonist provides cardioprotection during myocardial ischemia reperfusion in the mouse. Cardiovasc. Drugs Ther. 26, 273-276
35. Brough, D., Tyrrell, P. J., and Allan, S. M. (2011) Regulation of interleukin-1 in acute brain injury. Trends Pharmacol. Sci. 32, 617-622
36. Lukens, J. R., Vogel, P., Johnson, G. R., Kelliher, M. A., Iwakura, Y., Lamkanfi, M., and Kanneganti, T. D. (2013) RIP1-driven autoinflammation targets IL-1a independently of inflammasomes and RIP3. Nature 498, 224-227
37. Greenhalgh, A. D., Brough, D., Robinson, E. M., Girard, S., Rothwell, N. J., and Allan, S. M. (2012) Interleukin-1 receptor antagonist is beneficial after subarachnoid haemorrhage in rat by blocking haem-driven inflammatory pathology. Dis. Model Mech. 5, 823-833
38. Laird, M. D., Wakade, C, Alleyne, C. H, Jr., and Dhandapani, K. M. (2008) Hemin-induced necroptosis involves glutathione depletion in mouse astrocytes. FreeRadic. Biol. Med. 45, 1103-1114
39. Fortes, G. B., Alves, L. S., de Oliveira, R., Dutra, F. F., Rodrigues, D., Fernandez, P. L., Souto-Padron, T., De Rosa, M. J., Kelliher, M., Golenbock, D., Chan, F. K., and Bozza, M. T. (2012) Heme induces programmed necrosis on macrophages through autocrine TNF and ROS production. Blood 119, 2368-2375